Daniel Pereira

Chief Scientific Officer CrossBridge Bio

Seminars

Thursday 10th September 2026
Reflecting on the First Attempts with Novel Payloads, & What we are Doing Differently Now
8:45 am
  • What is the path to success for novel payloads, including how to navigate early assessment of payload platforms?
  • What are the challenges when doing something different and how are we decreasing risk when translating preclinical optimism into clinical success?
  • Discussing the panellists’ approach to business development. What would a win/ win business deal look like that focuses on payloads?
daniel pereira speaker at Oncology & Immunology Innovation Partnering